login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
LEXEO THERAPEUTICS INC (LXEO) Stock News
USA
- NASDAQ:LXEO -
US52886X1072
-
Common Stock
9.23
USD
-0.37 (-3.85%)
Last: 10/22/2025, 5:49:04 PM
9.1
USD
-0.13 (-1.41%)
After Hours:
10/22/2025, 5:49:04 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
LXEO Latest News, Press Relases and Analysis
All
Press Releases
15 days ago - By: Chartmill
- Mentions:
NAK
ACET
BTM
AEHR
...
Tuesday's session: gap up and gap down stocks
15 days ago - By: Chartmill
- Mentions:
NAK
NVX
AEHR
APVO
...
Stay updated with the stocks that are on the move in today's pre-market session.
2 days ago - By: Lexeo Therapeutics
Lexeo Therapeutics Announces Closing of Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares in the Public Offering
6 days ago - By: Lexeo Therapeutics
Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement
6 days ago - By: Lexeo Therapeutics
Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
15 days ago - By: Stocktwits
Lexeo Therapeutics Stock Hits 11-Month High On Bullish Analyst Calls For Friedreich’s Ataxia Gene Therapy — Retail Traders Join In
15 days ago - By: Benzinga
- Mentions:
SNWV
CLRB
APVO
SPRB
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
15 days ago - By: Benzinga
- Mentions:
NNE
APP
DGNX
NAK
...
James Hardie Industries, AMD, Trilogy Metals, BTQ Technologies And Other Big Stocks Moving Higher On Tuesday
15 days ago - By: Stocktwits
- Mentions:
IWMW
UWM
Lexeo Therapeutics Stock Rallies On Discussions With FDA To Expedite Friedreich’s Ataxia Drug Approval Process
16 days ago - By: Lexeo Therapeutics
Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval Pathway and Positive Interim Clinical Data for LX2006 in Friedreich Ataxia Cardiomyopathy
2 months ago - By: The Motley Fool
Lexeo Reports Q2 Loss as Costs Jump 129%
2 months ago - By: Lexeo Therapeutics
Lexeo Therapeutics Reports Second Quarter 2025 Financial Results and Operational Highlights
3 months ago - By: Yahoo Finance
- Mentions:
MSFT
HSBC
EBAY
UNH
...
Meta, Microsoft upgraded: Wall Street's top analyst calls
4 months ago - By: Lexeo Therapeutics
Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia
4 months ago - By: Lexeo Therapeutics
Lexeo Therapeutics, Perceptive Xontogeny Venture Funds and venBio Partners Announce Partnership to Advance Novel Cardiac RNA Therapeutics
5 months ago - By: Lexeo Therapeutics
Lexeo Therapeutics Announces $80 Million Equity Financing to Further Advance Development of Transformative Genetic Medicines for Cardiovascular Diseases
5 months ago - By: Lexeo Therapeutics
Lexeo Therapeutics Reports First Quarter 2025 Financial Results and Operational Highlights
6 months ago - By: Lexeo Therapeutics
Lexeo Therapeutics to Present New CMC Data at the 28th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
7 months ago - By: Lexeo Therapeutics
Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study
7 months ago - By: Stocktwits
- Mentions:
IWM
VTI
IBB
Lexeo Therapeutics Sees Biggest Retail Follower Surge Among Biotech Stocks After Record-Breaking Rally: What's The Big Draw?
7 months ago - By: Lexeo Therapeutics
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
Please enable JavaScript to continue using this application.